AVP and ischemic stroke: The above review explains that monitoring copeptin levels may help in several key moments for an ischemic stroke patient: prevention (copeptin predicting stroke occurrence among healthy individuals based on their comorbidities), moment of presentation (copeptin correlating with stroke severity and infarcted stroke volume), treatment efficacy, post-stroke complications, prognosis (short-term and long-term), mortality, risk stratification and stroke recurrence.